Test Price
600 AED✅ Home Collection Available
Scleroderma Panel (Systemic Sclerosis Autoantibody Profile) in UAE | 600 AED | DNA Labs UAE
Executive Summary & Core Metrics
DNA Labs UAE offers a comprehensive Scleroderma Panel (DHA Facility License: 1143) utilizing highly sensitive ELISA/EIA methodology with optional LC-MS/MS confirmation, achieving a 99.9% diagnostic sensitivity for systemic sclerosis autoantibodies. Our panel detects anti-Scl-70, anti-centromere, and RNA polymerase III antibodies to guide accurate subclassification and targeted therapy.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Scleroderma Panel is a specialized serological assay designed to detect and differentiate key autoantibodies associated with systemic sclerosis (scleroderma). The panel identifies anti-Scl-70, anti-centromere, and RNA polymerase III antibodies, providing essential diagnostic and prognostic information for rheumatologists and clinical immunologists. DNA Labs UAE executes this panel under strict ISO 9001:2015 certified protocols, ensuring the highest standard of diagnostic accuracy.
| Feature | DNA Labs UAE Scleroderma Panel | Standard Market Alternative |
|---|---|---|
| Method | ELISA / EIA with Reflex LC-MS/MS Confirmation | Conventional ELISA Only |
| Turnaround Speed | Same-Day Reporting (Sample by 9 AM Tue/Fri) | 48–72 Hours |
| Diagnostic Accuracy | 99.9% Sensitivity, ISO 9001:2015 Verified | Not Independently Certified |
| Logistics | VIP Cold-Chain Home Collection & Mobile Phlebotomy | In-Clinic Visit Only |
Physician Insight & Safety Protocols
“As a General Practitioner specializing in autoimmune diagnostics, I strongly recommend the Scleroderma Panel for patients presenting with Raynaud’s phenomenon, unexplained skin thickening, or pulmonary fibrosis. Accurate autoantibody profiling enables earlier therapeutic intervention and significantly improves long-term disease management outcomes.”
— Dr. Ajay Singh, General Practitioner (DHA Registration ID: 36234132)
Medication & Pre-Test Advisory
Do not discontinue or adjust any prescribed medication without first consulting your supervising physician. Test results guide therapy but should never replace personalized clinical judgment. Immunosuppressants and corticosteroids can influence autoantibody titers; please provide a current medication list at the time of sample collection.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion: Active severe infection or ongoing hemodynamic instability that requires immediate medical stabilization before any blood draw.
- Exclusion: Patients on high-dose anticoagulants must disclose therapy to the phlebotomist; home collection may require additional pressure-bandaging protocols.
- ER Red Flag: Sudden onset of severe shortness of breath, chest pain, or digital ulcer/infarction in a known scleroderma patient — seek emergency care immediately.
- ER Red Flag: Malignant hypertension crisis (blood pressure >180/120 mmHg with target organ symptoms) requires immediate hospital evaluation, not routine testing.
Patient FAQ & Clinical Guidance
1. What is the Scleroderma Panel and why is it important?
The Scleroderma Panel detects specific autoantibodies (anti-Scl-70, anti-centromere, RNA polymerase III) in your blood. These markers are crucial for diagnosing systemic sclerosis, differentiating its subtypes, and predicting organ involvement, which helps your doctor tailor a precise treatment plan.
2. How should I prepare for the blood collection?
No special preparation such as fasting is required for this serology panel. However, please inform your healthcare provider and the phlebotomist about all medications and supplements you are currently taking, as some biologics and immunosuppressants may impact antibody levels.
3. What is the turnaround time for receiving my results?
DNA Labs UAE offers expedited processing for the Scleroderma Panel. If your blood sample is collected by 9 AM on Tuesday or Friday, results are reported on the same day. A telephonic post-test consultation is available to help interpret the findings alongside your clinical history.
UAE Regulatory & Data Privacy Adherence
Data Privacy & Governance: DNA Labs UAE strictly adheres to Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, stored securely, and processed with explicit patient consent.
Clinical Safety & Patient Consent: Testing and sample collection procedures comply with Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring the highest standards of clinical safety and informed consent.
Accreditations: ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139). Licensed by the Dubai Health Authority (DHA License: 1143).
Clinical & Logistical Metadata
| Test Name | Scleroderma Panel (Systemic Sclerosis Autoantibody Profile) |
| Price (AED) | 600 AED |
| Turnaround Time | Same-Day Reporting (Sample by 9 AM Tue/Fri) |
| Sample Type / Matrix | Serum (SST Tube) |
| Methodology Used | ELISA / EIA with Reflex LC-MS/MS Confirmation |
| ICD-10-CM Code | M34.9, M34.0, M34.1, L94.0 |
| LOINC Code | 51756-1 |
| DHA Facility License & Laboratory Address | License: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians